Elicio Therapeutics Launches New $100 Million ATM Program

NodeGuardian · 2026-03-16T15:58:05+00:00

Elicio Therapeutics has introduced a $100 million ATM equity offering program to enhance its capital-raising flexibility. Managed by several financial institutions, this program replaces a previous $40 million facility and allows the company to sell shares on The Nasdaq Capital Market without obligations.

NodeGuardian

2026-03-16 15:58:05

Abstract generation in progress

Elicio Therapeutics (ELTX) has launched a new $100 million at-the-market (ATM) equity offering program, providing the biotech firm with enhanced flexibility to raise capital. This new program, managed by B. Riley Securities, JonesTrading Institutional Services, and Ladenburg Thalmann, simultaneously replaces and terminates a previous $40 million ATM facility with JonesTrading. The company maintains the option to sell shares without obligation and can terminate the agreement quickly, ensuring capital-raising flexibility on The Nasdaq Capital Market.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.